Traditional cancer therapy methods, especially those directed against specific intracellular
targets or signaling pathways, are not powerful enough to overcome tumor heterogeneity …

In recent decades, peptides, which can possess high potency, excellent selectivity, and low
toxicity, have emerged as promising therapeutics for cancer applications. Combined with an …

Nanomedicines based on synthetic polypeptides are among the most versatile and
advanced platforms for tumor therapy. Notably, several polypeptide-based nanodrugs are …

Cancer mortality is increasing at an alarming rate across the globe. Albeit, many
therapeutics are available commercially, they are not effective and have no cure up to today …

Nanomedicines are deemed as the most promising treatment modality for malignant
cancers. Particularly, cancer nanomedicines based on synthetic polypeptides have gained …

Peptides are an important class of biomaterials that are widely used in the biomedical field
due to their biocompatibility, bioavailability, and structural diversity. They self‐assemble into …

Peptides are attracting increasing attention as therapeutic agents, as the technologies for
peptide development and manufacture continue to mature. Concurrently, with booming …

The advancement of tissue and cell-specific drug delivery systems is a key to precision
cancer therapy. Peptides, with easy synthesis, low immunogenicity and biological functions …

Cancer is one of the leading causes of death worldwide. Conventional cancer therapies
mainly focus on mass cell killing without high specificity and often cause severe side effects …

Drug delivery systems for cancer therapeutics have revolutionized medicine. Delivery
systems have improved the efficacy and reduced the toxicity of current therapies and …